Johnson & Johnson (JNJ) 


 Summary
 Company Events
 Profile
 Headlines
 Message Boards
 Historical Prices
 Balance Sheet
1DAY Chart
Market.cap:177.36B
Full Time Employees:114000

Index Membership
0
0
0
0
0
0
0
0
Sector:Healthcare
Industly:Drug Manufacturers - Major
Healthcare-Drug Manufacturers - Major(YHOH783)
Dow Jones Industrial Average
NASDAQ Composite
S&P 500 INDEX,RTH
NYSE COMPOSITE INDEX (NEW METHO
Daily Chart

Daily Chart

3DAY Chart


Weekly Chart


Monthly Chart


Monthly Chart    Range:max
3DAY Chart


Weekly Chart


Monthly Chart


Monthly Chart    Range:max
- Linear Charts -
Daily Chart

3DAY Chart


Weekly Chart


Monthly Chart


Monthly Chart    Range:max
Daily Chart

3DAY Chart


Weekly Chart


Monthly Chart


Monthly Chart    Range:max
COMPARISON CHART    JNJ & DJI
Business Summary
Johnson & Johnson engages in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The Consumer segment provides products used in baby care, skin care, oral care, wound care, and women?s health care fields, as well as nutritional, over-the-counter pharmaceutical products, and wellness and prevention platforms under the brands of JOHNSON?S, AVEENO, CLEAN & CLEAR, JOHNSON?S Adult, NEUTROGENA, RoC, LUBRIDERM, DABAO, LISTERINE, REACH, BAND-AID, CAREFREE, STAYFREE, SPLENDA, TYLENOL, SUDAFED, ZYRTEC, MOTRIN IB, and PEPCID AC. The Pharmaceutical segment offers products in various therapeutic areas, such as anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, and virology. Its principal products include REMICADE for the treatment of immune mediated inflammatory diseases; STELARA for the treatment of moderate to severe plaque psoriasis; SIMPONI, a treatment for adults with moderate to severe rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis; VELCADE for the treatment of multiple myeloma; PREZISTA and INTELENCE for treating HIV/AIDS patients; NUCYNTA for moderate to severe acute pain; INVEGA SUSTENNAtm for the acute and maintenance treatment of schizophrenia in adults; RISPERDAL CONSTA for the management of bipolar I disorder and schizophrenia; and PROCRIT to stimulate red blood cell production. The Medical Devices and Diagnostics segment primarily offers circulatory disease management products; orthopaedic joint reconstruction, spinal care, and sports medicine products; surgical care, aesthetics, and women?s health products; blood glucose monitoring and insulin delivery products; professional diagnostic products; and disposable contact lenses. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Copyright (C) 2007- kabuoudou. All rights reserved.
Worid RealTime Stock Index  http://kabuoudou.web.fc2.com/world/world.html